버텍스 파마슈티컬 (VRTX)

Shares of Vertex Pharmaceuticals (VRTX) dropped by 5.31% from $27.70 to $26.23 in the trading on Wednesday, Novemeber 15, 2023. The reason why VRTX is down today is due to insider trading activity within the company. The decline in VRTX's share price is a result of insider trading involving Vertex Pharmaceuticals' CEO. The CEO sold 5,097 shares of the company's stock at a price of $377 per share. This insider trading activity, where a top executive sells a significant number of shares, may have triggered concerns among investors, leading to the decline in VERX's stock price. Investors often interpret such actions as an insider's lack of confidence in the company's future performance, which can impact market sentiment.